Dr Reddys Laboratories Quarterly Results for Trading Insights

DRREDDY • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1,337 Cr
QSept 2025
Quarterly Results

Dr Reddys Laboratories Quarterly Results Key Highlights

  • Revenue of ₹9,135 Cr in Sept 2025 (+1.1% vs Mar 2025, +9.7% vs Sept 2024)
  • Net Profit of ₹1,337 Cr in Sept 2025 (-15.8% vs Mar 2025, -0.4% vs Sept 2024)
  • EBITDA of ₹2,317 Cr in Sept 2025 (-7.4% vs Mar 2025)
  • Operating Margin of 23.0% in Sept 2025 (+0.0pp vs Mar 2025)
  • Earnings Per Share of ₹16.18 in Sept 2025 (-15.4% vs Mar 2025)

Dr Reddys Laboratories Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 9,135 9,034 8,836 8,998 8,330 1.1% 9.7%
Net Profit (₹ Cr) 1,337 1,587 1,410 1,190 1,342 - -
EBITDA (₹ Cr) 2,317 2,503 2,437 2,132 2,368 - -
EPS (₹) 16.18 19.12 17.04 14.53 75.40 - -
Operating Margin (%) 23.0% 23.0% 25.0% 21.0% 26.0% - -

Dr Reddys Laboratories Share Price Trend Around Quarterly Results

Visualize Dr Reddys Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Dr Reddys Laboratories

Additional stock information and data for DRREDDY

Dr Reddys Laboratories share price chart
DRREDDY price earnings ratio
DRREDDY yearly price range

Profitability Ratios

Profit Margin 14.6%
EBITDA Margin 25.4%
Operating Margin 23.0%
ROE (Annual) 15.8%

Balance Sheet Highlights

Total Assets ₹49,427 Cr
Total Equity ₹33,927 Cr
Current Assets ₹25,018 Cr
Current Liabilities ₹2,465 Cr

Cash Flow Analysis

Operating Cash Flow ₹4,643 Cr
Investing Cash Flow ₹-5,785 Cr
Financing Cash Flow ₹1,891 Cr
Net Cash Flow ₹749 Cr

Current Market Data

Current Price ₹1196.10
Exchange NSE
Last Updated Apr 07, 2026

Revenue Trend (₹ Cr)

Dec 2025 8,998
Jun 2025 8,836
Mar 2025 9,034
Sept 2025 9,135

Net Profit Trend (₹ Cr)

Dec 2025 1,190
Jun 2025 1,410
Mar 2025 1,587
Sept 2025 1,337

Operating Margin Trend (%)

Dec 2025 21.0%
Jun 2025 25.0%
Mar 2025 23.0%
Sept 2025 23.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Dr Reddys Laboratories quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹406,351.37 Cr 1718.0 14,875 3,125 +10.8% - 21.0% 132.2
Divis Laboratories
Sept 2025 		₹155,471.67 Cr 5850.0 2,860 689 +7.1% - 24.1% 225.3
Torrent Pharmaceuti…
Sept 2025 		₹134,945.00 Cr 4051.3 3,219 591 +11.3% - 18.4% 231.0
Lupin
Sept 2025 		₹102,578.78 Cr 2298.3 6,921 1,485 +23.2% - 21.5% 71.0
Cipla
Sept 2025 		₹96,319.77 Cr 1202.4 7,716 1,353 +12.0% - 17.5% 71.9
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores